Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06434324 · ClinicalTrials.gov registry record · NA

Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion

A NA study of Pleural Infection, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06434324: Recruiting NA study of Pleural Infection, sponsored by Mayo Clinic.

NCT06434324 is a NA study of Pleural Infection that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06434324, a NA study of Pleural Infection, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if there is any benefit in adding saline irrigation through a chest tube to the standard course of treatment for people diagnosed or suspected of having a pleural space infection.

Primary Outcome

Number of intrapleural fibrinolytic doses to achieve adequate pleural space evacuation (defined as \<=2.5 cm separation between parietal and visceral pleural layers on bedside ultrasound or no more than small residual effusion on clinically-directed CT chest imaging).

Conditions Studied

Interventions

  • PROCEDURE Saline Irrigation

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-29
Est. Completion 2026-05-04
Phase NA
Mayo Clinic

2,844 total trials

What NCT06434324 shows while recruiting

NCT06434324 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Pleural Infection appearing as the primary indexed condition, and to 1 intervention - of which Saline Irrigation is the first listed.

NCT06434324 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06434324 about?

NCT06434324 is a clinical study titled "Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion". The purpose of this study is to see if there is any benefit in adding saline irrigation through a chest tube to the standard course of treatment for people diagnosed or suspected of having a pleural space infection.

What is the current status of trial NCT06434324?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-29. Estimated completion is 2026-05-04.

What conditions does trial NCT06434324 study?

This clinical trial studies the following conditions: Pleural Infection.

What interventions are being tested in trial NCT06434324?

The interventions under investigation include: Saline Irrigation (PROCEDURE).

Who is sponsoring clinical trial NCT06434324?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06434324 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pleural Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06434324's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06434324, the US trial registry maintained by the National Library of Medicine. NCT06434324 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.